Product Information

OXTELLAR XR 600 MG TABLET is a brand product labeled by Supernus Pharmaceuticals Inc., priced at $23.2032 per EA under NDC 17772012301. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the OXCARBAZEPINE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OXTELLAR XR 600 MG TABLET

OXCARBAZEPINE
$23.2032per EA
High Outlier

Strength

600 mg/1

NDC

17772012301

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

New Drug (NDA)

FDA Application

NDA202810

On Market Since

1/17/2013

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXTELLAR XR 600 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 217.6%. The table below summarizes its recorded NADAC range and movement.

Current price$23.2032 per EA
All-time high$23.2967 (Sep 10, 2025)
All-time low$7.3069 (Nov 28, 2013)
52-week high$23.2967
52-week low$23.2032
Median price$17.4253
Average price$16.5557
Largest weekly change+13.9% (Jul 23, 2014)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

-0.4%

1Y

-0.3%

3Y

+11.5%

5Y

+25.3%

All

+217.6%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OXTELLAR XR 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXTELLAR XR 600 MG TABLET, manufactured by Supernus Pharmaceuticals Inc., is $23.2032 per EA (NDC 17772012301), effective Jun 24, 2026.

How has the price of OXTELLAR XR 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXTELLAR XR 600 MG TABLET has risen 217.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for OXTELLAR XR 600 MG TABLET?

Since Nov 28, 2013, the NADAC for OXTELLAR XR 600 MG TABLET has ranged from a low of $7.3069 (Nov 28, 2013) to a high of $23.2967 (Sep 10, 2025), with a median of $17.4253 per EA.

Are there cheaper alternatives to OXTELLAR XR 600 MG TABLET?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OXCARBAZEPINE 600 MG TABLET, is $0.3080 per EA — about 99% below OXTELLAR XR 600 MG TABLET.

Who manufactures OXTELLAR XR 600 MG TABLET?

OXTELLAR XR 600 MG TABLET (NDC 17772012301) is labeled by Supernus Pharmaceuticals Inc., and CMS classifies it as a brand product.